T SCIENTIFIC CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,206 KRW | +1.26% |
|
+3.61% | -27.91% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 199,982 | 137,051 | 114,615 |
| Enterprise Value (EV) 1 | 195,188 | 140,512 | 113,754 |
| P/E ratio | -62.6 x | -11.8 x | -2.27 x |
| Yield | - | - | - |
| Capitalization / Revenue | 19.8 x | 15.8 x | 4.28 x |
| EV / Revenue | 19.4 x | 16.2 x | 4.25 x |
| EV / EBITDA | 154 x | -68 x | -26.6 x |
| EV / FCF | - | -65,248,878 x | -250,640,599 x |
| FCF Yield | - | -0% | -0% |
| Price to Book | 0.9 x | 0.77 x | 0.87 x |
| Nbr of stocks (in thousands) | 47,333 | 55,262 | 68,509 |
| Reference price 2 | 4,225 | 2,480 | 1,673 |
| Announcement Date | 3/21/23 | 3/21/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 10,084 | 8,694 | 26,769 |
| EBITDA 1 | 1,269 | -2,067 | -4,279 |
| EBIT 1 | 1,004 | -2,492 | -5,616 |
| Operating Margin | 9.96% | -28.66% | -20.98% |
| Earnings before Tax (EBT) 1 | -2,959 | -15,890 | -54,262 |
| Net income 1 | -3,162 | -11,110 | -45,414 |
| Net margin | -31.36% | -127.79% | -169.65% |
| EPS 2 | -67.48 | -210.0 | -737.0 |
| Free Cash Flow | - | -2,153 | -453.9 |
| FCF margin | - | -24.77% | -1.7% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 3/21/23 | 3/21/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | - | 3,461 | - |
| Net Cash position 1 | 4,793 | - | 862 |
| Leverage (Debt/EBITDA) | - | -1.675 x | - |
| Free Cash Flow | - | -2,153 | -454 |
| ROE (net income / shareholders' equity) | - | -5.87% | -31.3% |
| ROA (Net income/ Total Assets) | - | -0.56% | -1.61% |
| Assets 1 | - | 1,993,609 | 2,824,085 |
| Book Value Per Share 2 | 4,688 | 3,220 | 1,916 |
| Cash Flow per Share 2 | 89.80 | 201.0 | 124.0 |
| Capex 1 | 81.5 | 411 | 239 |
| Capex / Sales | 0.81% | 4.72% | 0.89% |
| Announcement Date | 3/21/23 | 3/21/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -27.91% | 59.7M | |
| -14.66% | 189B | |
| +0.72% | 166B | |
| +1.15% | 152B | |
| +8.63% | 99.37B | |
| +6.11% | 77.36B | |
| +15.21% | 70.76B | |
| -7.93% | 70.46B | |
| -21.62% | 51.83B | |
| -6.79% | 44.34B |
- Stock Market
- Equities
- A057680 Stock
- Financials T Scientific Co.,Ltd.
